{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:30:45Z","timestamp":1783769445477,"version":"3.55.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40257-026-01012-7","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:49:28Z","timestamp":1773848968000},"page":"465-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exposome Risk Factors for Vitiligo: A Systematic Evidence Review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-5602","authenticated-orcid":false,"given":"Jaime","family":"Piquero-Casals","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1796-2076","authenticated-orcid":false,"given":"Cl\u00e9mence","family":"Bertold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2350-5282","authenticated-orcid":false,"given":"Agust\u00edn","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4704-6132","authenticated-orcid":false,"given":"Daniel","family":"Morgado-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8034-3617","authenticated-orcid":false,"given":"Yolanda","family":"Gilaberte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-1989","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"L\u00f3pez-Estebaranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-5765","authenticated-orcid":false,"given":"Caio Silva","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6120-2712","authenticated-orcid":false,"given":"Giovanni","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-1115","authenticated-orcid":false,"given":"Henry W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8433-1517","authenticated-orcid":false,"given":"Jean","family":"Krutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-4589","authenticated-orcid":false,"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-6570","authenticated-orcid":false,"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711080","volume":"12","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Harris JE, Le Poole IC, Passeron T, Speeckaert R, Boniface K. Editorial: immunology of vitiligo. Front Immunol. 2021;12:711080. https:\/\/doi.org\/10.3389\/fimmu.2021.711080.","journal-title":"Front Immunol"},{"issue":"8","key":"1012_CR2","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1158\/1055-9965.EPI-05-0456","volume":"14","author":"CP Wild","year":"2005","unstructured":"Wild CP. Complementing the genome with an \u201cexposome\u201d: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1847\u201350. https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0456.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"1012_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jdv.16614","volume":"34","author":"T Passeron","year":"2020","unstructured":"Passeron T, Krutmann J, Andersen ML, Katta R, Zouboulis CC. Clinical and biological impact of the exposome on the skin. J Eur Acad Dermatol Venereol. 2020;34(4):4\u201325. https:\/\/doi.org\/10.1111\/jdv.16614.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1012_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613056","volume":"12","author":"K Boniface","year":"2021","unstructured":"Boniface K, Passeron T, Seneschal J, Tulic MK. Targeting innate immunity to combat cutaneous stress: the vitiligo perspective. Front Immunol. 2021;12:613056. https:\/\/doi.org\/10.3389\/fimmu.2021.613056.","journal-title":"Front Immunol"},{"key":"1012_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.freeradbiomed.2018.08.022","volume":"126","author":"P Kang","year":"2018","unstructured":"Kang P, Zhang W, Chen X, et al. TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress. Free Radic Biol Med. 2018;126:259\u201368. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.08.022.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1012_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jid.2017.02.004","volume":"137","author":"R Dunlap","year":"2017","unstructured":"Dunlap R, Wu S, Wilmer E, et al. Pigmentation traits, sun exposure, and risk of incident vitiligo in women. J Invest Dermatol. 2017;137(6):1234\u20139. https:\/\/doi.org\/10.1016\/j.jid.2017.02.004.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"1012_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1346-8138.2010.00834.x","volume":"37","author":"JU Shin","year":"2010","unstructured":"Shin JU, Roh MR, Lee JH. Vitiligo following intense pulsed light treatment. J Dermatol. 2010;37(7):674\u20136. https:\/\/doi.org\/10.1111\/j.1346-8138.2010.00834.x.","journal-title":"J Dermatol"},{"issue":"5","key":"1012_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/bjd.12162","volume":"168","author":"C Vrijman","year":"2013","unstructured":"Vrijman C, Hosseinpour D, Bakker JG, et al. Provoking factors, including chemicals, in Dutch patients with vitiligo. Br J Dermatol. 2013;168(5):1003\u201311. https:\/\/doi.org\/10.1111\/bjd.12162.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1012_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02942-0","volume":"316","author":"S Gonzalez","year":"2024","unstructured":"Gonzalez S, Mora Hurtado AC, Syder NC, Rodman J, Elbuluk N. Perception of skin cancer risk and sun protective practices in individuals with vitiligo: a prospective international cross-sectional survey. Arch Dermatol Res. 2024;316(5):189. https:\/\/doi.org\/10.1007\/s00403-024-02942-0.","journal-title":"Arch Dermatol Res"},{"key":"1012_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1333811","volume":"12","author":"H Hu","year":"2024","unstructured":"Hu H, Yang X, Chen Q, et al. Causal association between air pollution and autoimmune diseases: a two-sample Mendelian randomization study. Front Public Health. 2024;12:1333811. https:\/\/doi.org\/10.3389\/fpubh.2024.1333811.","journal-title":"Front Public Health"},{"key":"1012_CR12","doi-asserted-by":"publisher","unstructured":"Liu CY, Hsu YH, Chen YL, et al. Association between long-term exposure to air pollution and the risk of vitiligo: a nationwide retrospective cohort study in Taiwan [dataset]. Mendeley Data 2024;V1. https:\/\/doi.org\/10.17632\/6n469p2r2c.1.","DOI":"10.17632\/6n469p2r2c.1"},{"issue":"1","key":"1012_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12930","volume":"40","author":"Y Enomoto","year":"2024","unstructured":"Enomoto Y, Kanayama Y, Ikumi K, Sakurai M, Yamamoto A, Morita A. Cigarette smoking is an independent risk factor for developing vitiligo on the hands. Photodermatol Photoimmunol Photomed. 2024;40(1):10.1111\/phpp.12930. https:\/\/doi.org\/10.1111\/phpp.12930.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1012_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440705","volume":"15","author":"X Liang","year":"2024","unstructured":"Liang X, Guo F, Fan Q, et al. Healthy lifestyle choices: new insights into vitiligo management. Front Immunol. 2024;15:1440705. https:\/\/doi.org\/10.3389\/fimmu.2024.1440705.","journal-title":"Front Immunol"},{"issue":"1","key":"1012_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63384-y","volume":"10","author":"YB Lee","year":"2020","unstructured":"Lee YB, Lee JH, Lee SY, Yu DS, Han KD, Park YG. Association between vitiligo and smoking: a nationwide population-based study in Korea. Sci Rep. 2020;10(1):6231. https:\/\/doi.org\/10.1038\/s41598-020-63384-y.","journal-title":"Sci Rep"},{"issue":"1","key":"1012_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.1365-2133.2003.05024.x","volume":"148","author":"Y Gauthier","year":"2003","unstructured":"Gauthier Y, Cario-Andre M, Lepreux S, Pain C, Ta\u00efeb A. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol. 2003;148(1):95\u2013101. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05024.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1012_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jdv.13301","volume":"30","author":"KA Engebretsen","year":"2016","unstructured":"Engebretsen KA, Johansen JD, Kezic S, Linneberg A, Thyssen JP. The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol. 2016;30(2):223\u201349. https:\/\/doi.org\/10.1111\/jdv.13301.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1012_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.det.2016.11.006","volume":"35","author":"JE Harris","year":"2017","unstructured":"Harris JE. Chemical-induced vitiligo. Dermatol Clin. 2017;35(2):151\u201361. https:\/\/doi.org\/10.1016\/j.det.2016.11.006.","journal-title":"Dermatol Clin"},{"issue":"4","key":"1012_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s43188-022-00144-2","volume":"38","author":"M Kim","year":"2022","unstructured":"Kim M, Lim KM. Melanocytotoxic chemicals and their toxic mechanisms. Toxicol Res. 2022;38(4):417\u201335. https:\/\/doi.org\/10.1007\/s43188-022-00144-2.","journal-title":"Toxicol Res"},{"issue":"4","key":"1012_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1473-2165.2002.00069.x","volume":"1","author":"SB Verma","year":"2002","unstructured":"Verma SB. Vitiligo koebnerized by eyebrow plucking by threading. J Cosmet Dermatol. 2002;1(4):214\u20135. https:\/\/doi.org\/10.1111\/j.1473-2165.2002.00069.x.","journal-title":"J Cosmet Dermatol"},{"key":"1012_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.169711","volume":"913","author":"N Chivukula","year":"2024","unstructured":"Chivukula N, Ramesh K, Subbaroyan A, et al. ViCEKb: vitiligo-linked chemical exposome knowledgebase. Sci Total Environ. 2024;913:169711. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.169711.","journal-title":"Sci Total Environ"},{"key":"1012_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2025.106018","volume":"104","author":"S Ghosh","year":"2025","unstructured":"Ghosh S, Pandey SK, Roy K. Predictive classification-based read-across for diverse functional vitiligo-linked chemical exposomes (ViCE): a new approach for the assessment of chemical safety for the vitiligo disease in humans. Toxicol In Vitro. 2025;104:106018. https:\/\/doi.org\/10.1016\/j.tiv.2025.106018.","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"1012_CR23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1365-2133.1996.tb03898.x","volume":"135","author":"SW Koo","year":"1996","unstructured":"Koo SW, Suh CO, Hann SK. Vitiligo following radiotherapy for carcinoma of the breast. Br J Dermatol. 1996;135(5):852\u20133. https:\/\/doi.org\/10.1111\/j.1365-2133.1996.tb03898.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1012_CR24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/pcmr.12402","volume":"28","author":"S Wu","year":"2015","unstructured":"Wu S, Li WQ, Cho E, Harris JE, Speizer F, Qureshi AA. Use of permanent hair dyes and risk of vitiligo in women. Pigment Cell Melanoma Res. 2015;28(6):744\u20136. https:\/\/doi.org\/10.1111\/pcmr.12402.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"1012_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000104261","volume":"215","author":"A Kalayciyan","year":"2007","unstructured":"Kalayciyan A, Aydemir EH, Kotogyan A. Experimental Koebner phenomenon in patients with psoriasis. Dermatology. 2007;215(2):114\u20137. https:\/\/doi.org\/10.1159\/000104261.","journal-title":"Dermatology"},{"issue":"6","key":"1012_CR26","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jaad.2022.07.042","volume":"87","author":"MR Mansour","year":"2022","unstructured":"Mansour MR, Abushukur Y, Rehman RA, Shah C, Mehregan D. Radiotherapy-induced vitiligo: a systematic review of patient demographics and clinical characteristics of vitiligo following radiation therapy. J Am Acad Dermatol. 2022;87(6):1445\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2022.07.042.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1012_CR27","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1111\/1346-8138.14695","volume":"46","author":"JW Lee","year":"2019","unstructured":"Lee JW, Hwang S, Park MY, Oh SH. Aggravation of vitiligo by an electric heating pad: a possible case of heat-triggered Koebnerization in vitiligo. J Dermatol. 2019;46(5):e165\u20137. https:\/\/doi.org\/10.1111\/1346-8138.14695.","journal-title":"J Dermatol"},{"issue":"1","key":"1012_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cod.13813","volume":"85","author":"S Sinha","year":"2021","unstructured":"Sinha S, Savitha B, Sardana K. \u201cMask vitiligo\u201d secondary to frictional dermatitis from surgical masks. Contact Dermatitis. 2021;85(1):121\u20133. https:\/\/doi.org\/10.1111\/cod.13813.","journal-title":"Contact Dermatitis"},{"issue":"8","key":"1012_CR29","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00403-023-02611-8","volume":"315","author":"NF Post","year":"2023","unstructured":"Post NF, Van Broekhoven NX, Lommerts A, et al. Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study. Arch Dermatol Res. 2023;315(8):2289\u201394. https:\/\/doi.org\/10.1007\/s00403-023-02611-8.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"1012_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamadermatol.2023.4933","volume":"160","author":"CH Bang","year":"2024","unstructured":"Bang CH, Park HE, Kim YH, et al. Risk of subsequent vitiligo in transplant recipients with comorbid graft-vs-host disease. JAMA Dermatol. 2024;160(2):194\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2023.4933.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"1012_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41409-019-0626-x","volume":"55","author":"A Totani","year":"2020","unstructured":"Totani A, Amin H, Bacchi S, Lewis I. Vitiligo following stem-cell transplant. Bone Marrow Transplant. 2020;55(2):332\u201340. https:\/\/doi.org\/10.1038\/s41409-019-0626-x.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"1012_CR32","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1111\/petr.12412","volume":"19","author":"J Sheu","year":"2015","unstructured":"Sheu J, Saavedra AP, Degar BA, et al. Bone marrow engraftment and associated dermatologic sequelae in a three-yr-old after liver transplantation. Pediatr Transplant. 2015;19(2):E41\u20136. https:\/\/doi.org\/10.1111\/petr.12412.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"1012_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaad.2017.08.015","volume":"78","author":"JM Bae","year":"2018","unstructured":"Bae JM, Choi KH, Choi JY, Kim M, Kim GM, Yu DS, et al. Decreased risk of vitiligo in organ transplant recipients: a population-based cohort study. J Am Acad Dermatol. 2018;78(1):211\u20132. https:\/\/doi.org\/10.1016\/j.jaad.2017.08.015.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1012_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10071087","volume":"10","author":"F Guarneri","year":"2021","unstructured":"Guarneri F, Bertino L, Pioggia G, Casciaro M, Gangemi S. Therapies with antioxidant potential in psoriasis, vitiligo, and lichen planus. Antioxidants. 2021;10(7):1087. https:\/\/doi.org\/10.3390\/antiox10071087.","journal-title":"Antioxidants"},{"issue":"9","key":"1012_CR35","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/j.jid.2021.01.036","volume":"141","author":"H Bzioueche","year":"2021","unstructured":"Bzioueche H, Simonyt\u00e9 Sj\u00f6din K, West CE, et al. Analysis of matched dkin and gut microbiome of patients with vitiligo reveals deep skin dysbiosis: link with mitochondrial and immune changes. J Invest Dermatol. 2021;141(9):2280\u201390. https:\/\/doi.org\/10.1016\/j.jid.2021.01.036.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1012_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1175-y","volume":"15","author":"RK Singh","year":"2017","unstructured":"Singh RK, Chang HW, Yan D, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15(1):73. https:\/\/doi.org\/10.1186\/s12967-017-1175-y.","journal-title":"J Transl Med"},{"issue":"4","key":"1012_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/1346-8138.17163","volume":"51","author":"R Hamada","year":"2024","unstructured":"Hamada R, Funasaka Y, Saeki H, et al. Dietary habits in adult Japanese patients with vitiligo. J Dermatol. 2024;51(4):491\u2013508. https:\/\/doi.org\/10.1111\/1346-8138.17163.","journal-title":"J Dermatol"},{"issue":"2","key":"1012_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1525-1470.2011.01388.x","volume":"28","author":"C Rodr\u00edguez-Garc\u00eda","year":"2011","unstructured":"Rodr\u00edguez-Garc\u00eda C, Gonz\u00e1lez-Hern\u00e1ndez S, P\u00e9rez-Robayna N, Guimer\u00e1 F, Fagundo E, S\u00e1nchez R. Repigmentation of vitiligo lesions in a child with celiac disease after a gluten-free diet. Pediatr Dermatol. 2011;28(2):209\u201310. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01388.x.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"1012_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000370303","volume":"6","author":"BN Khandalavala","year":"2014","unstructured":"Khandalavala BN, Nirmalraj MC. Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet. Case Rep Dermatol. 2014;6(3):283\u20137. https:\/\/doi.org\/10.1159\/000370303.","journal-title":"Case Rep Dermatol"},{"issue":"12","key":"1012_CR40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00105-019-04482-5","volume":"70","author":"J Henker","year":"2019","unstructured":"Henker J, Hartmann A. Pr\u00e4valenz der Assoziation von Z\u00f6liakie und Vitiligo [Prevalence of an association between coeliac disease and vitiligo]. Hautarzt. 2019;70(12):960\u20133. https:\/\/doi.org\/10.1007\/s00105-019-04482-5.","journal-title":"Hautarzt"},{"issue":"3","key":"1012_CR41","first-page":"154","volume":"41","author":"V Ertekin","year":"2009","unstructured":"Ertekin V, Selimoglu MA, Altinkaynak S. Celiac disease in childhood: evaluation of 140 patients. Eurasian J Med. 2009;41(3):154\u20137.","journal-title":"Eurasian J Med"},{"issue":"579","key":"1012_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/pgmj.50.579.45","volume":"50","author":"MJ Lancaster-Smith","year":"1974","unstructured":"Lancaster-Smith MJ, Perrin J, Swarbrick ET, Wright JT. Coeliac disease and autoimmunity. Postgrad Med J. 1974;50(579):45\u20138. https:\/\/doi.org\/10.1136\/pgmj.50.579.45.","journal-title":"Postgrad Med J"},{"issue":"1","key":"1012_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1525-1470.2007.00328.x","volume":"24","author":"M Seyhan","year":"2007","unstructured":"Seyhan M, Erdem T, Ertekin V, Selimo\u011flu MA. The mucocutaneous manifestations associated with celiac disease in childhood and adolescence. Pediatr Dermatol. 2007;24(1):28\u201333. https:\/\/doi.org\/10.1111\/j.1525-1470.2007.00328.x.","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"1012_CR44","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/ng.602","volume":"42","author":"Y Jin","year":"2010","unstructured":"Jin Y, Birlea SA, Fain PR, et al. Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet. 2010;42(7):576\u20138. https:\/\/doi.org\/10.1038\/ng.602.","journal-title":"Nat Genet"},{"issue":"6","key":"1012_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng.2272","volume":"44","author":"Y Jin","year":"2012","unstructured":"Jin Y, Birlea SA, Fain PR, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44(6):676\u201380. https:\/\/doi.org\/10.1038\/ng.2272.","journal-title":"Nat Genet"},{"issue":"2","key":"1012_CR46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/jid.2010.337","volume":"131","author":"SA Birlea","year":"2011","unstructured":"Birlea SA, Jin Y, Bennett DC, et al. Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol. 2011;131(2):371\u201381. https:\/\/doi.org\/10.1038\/jid.2010.337.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1012_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.abd.2019.07.006","volume":"95","author":"E Tanacan","year":"2020","unstructured":"Tanacan E, Atakan N. Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study. An Bras Dermatol. 2020;95(2):165\u201372. https:\/\/doi.org\/10.1016\/j.abd.2019.07.006.","journal-title":"An Bras Dermatol"},{"issue":"1","key":"1012_CR48","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.dsx.2016.12.009","volume":"11","author":"YK Sharma","year":"2017","unstructured":"Sharma YK, Bansal P, Menon S, Prakash N. Metabolic syndrome in vitiligo patients among a semi-urban Maharashtrian population: a case control study. Diabetes Metab Syndr. 2017;11(1):S77-80. https:\/\/doi.org\/10.1016\/j.dsx.2016.12.009.","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"1012_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-023-02803-2","volume":"316","author":"K Kamal","year":"2024","unstructured":"Kamal K, Xiang DH, Young K, et al. Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case-control study in the All of Us Research Program. Arch Dermatol Res. 2024;316(2):79. https:\/\/doi.org\/10.1007\/s00403-023-02803-2.","journal-title":"Arch Dermatol Res"},{"key":"1012_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdcr.2022.05.042","volume":"26","author":"LM Assaedi","year":"2022","unstructured":"Assaedi LM, Alshamrani HM, Abbas RA, Alghamdi FA. Carbamazepine-induced reversible vitiligo. JAAD Case Rep. 2022;26:3\u20135. https:\/\/doi.org\/10.1016\/j.jdcr.2022.05.042.","journal-title":"JAAD Case Rep"},{"issue":"2","key":"1012_CR51","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2340\/0001555576166167","volume":"76","author":"E Selvaag","year":"1996","unstructured":"Selvaag E. Chloroquine-induced vitiligo: a case report and review of the literature. Acta Derm Venereol. 1996;76(2):166\u20137. https:\/\/doi.org\/10.2340\/0001555576166167.","journal-title":"Acta Derm Venereol"},{"issue":"11","key":"1012_CR52","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1345\/aph.19090","volume":"33","author":"M Sabat\u00e9","year":"1999","unstructured":"Sabat\u00e9 M, Bosch A, Pedr\u00f3s C, Figueras A. Vitiligo associated with tolcapone and levodopa in a patient with Parkinson\u2019s disease. Ann Pharmacother. 1999;33(11):1228\u20139. https:\/\/doi.org\/10.1345\/aph.19090.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"1012_CR53","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2133.1990.tb06306.x","volume":"123","author":"P Duhra","year":"1990","unstructured":"Duhra P, Foulds IS. Persistent vitiligo induced by diphencyprone. Br J Dermatol. 1990;123(3):415\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.1990.tb06306.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1012_CR54","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/clinids\/22.3.581-a","volume":"22","author":"V Brown-Harrell","year":"1996","unstructured":"Brown-Harrell V, Nitta AT, Goble M. Apparent exacerbation of vitiligo syndrome in a patient with pulmonary Mycobacterium avium complex disease who received clofazimine therapy. Clin Infect Dis. 1996;22(3):581\u20132. https:\/\/doi.org\/10.1093\/clinids\/22.3.581-a.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1012_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1365-2133.1995.tb08660.x","volume":"132","author":"KU Schallreuter","year":"1995","unstructured":"Schallreuter KU. Beta-adrenergic blocking drugs may exacerbate vitiligo. Br J Dermatol. 1995;132(1):168\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb08660.x.","journal-title":"Br J Dermatol"},{"issue":"Suppl. 4","key":"1012_CR56","first-page":"66","volume":"58","author":"K Curzytek","year":"2007","unstructured":"Curzytek K, Pietowska J, Spiewak R. Drug-induced vitiligo: a meta-analysis of reported cases. J Physiol Pharmacol. 2007;58(Suppl. 4):66.","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"1012_CR57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.0736-8046.2004.21512.x","volume":"21","author":"D Se\u00e7kin","year":"2004","unstructured":"Se\u00e7kin D, Durusoy C, Sahin S. Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection. Pediatr Dermatol. 2004;21(5):577\u20139. https:\/\/doi.org\/10.1111\/j.0736-8046.2004.21512.x.","journal-title":"Pediatr Dermatol"},{"key":"1012_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/387140","volume":"2012","author":"E Guney","year":"2012","unstructured":"Guney E, Akcali G, Akcay BI, et al. Vitiligo in a patient treated with interferon alpha-2a for Beh\u00e7et\u2019s disease. Case Rep Med. 2012;2012:387140. https:\/\/doi.org\/10.1155\/2012\/387140.","journal-title":"Case Rep Med"},{"issue":"7","key":"1012_CR59","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1365-4632.2009.04443.x","volume":"49","author":"I Hamadah","year":"2010","unstructured":"Hamadah I, Binamer Y, Sanai FM, Abdo AA, Alajlan A. Interferon-induced vitiligo in hepatitis C patients: a case series. Int J Dermatol. 2010;49(7):829\u201333. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04443.x.","journal-title":"Int J Dermatol"},{"issue":"8","key":"1012_CR60","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/imj.13498","volume":"47","author":"RP Luber","year":"2017","unstructured":"Luber RP, Chamberlain AJ, Sparrow MP. New onset vitiligo following commencement of infliximab in Crohn disease. Intern Med J. 2017;47(8):972\u20133. https:\/\/doi.org\/10.1111\/imj.13498.","journal-title":"Intern Med J"},{"issue":"5","key":"1012_CR61","doi-asserted-by":"publisher","first-page":"620","DOI":"10.5021\/ad.2015.27.5.620","volume":"27","author":"JM Jung","year":"2015","unstructured":"Jung JM, Lee YJ, Won CH, et al. Development of vitiligo during treatment with adalimumab: a plausible or paradoxical response? Ann Dermatol. 2015;27(5):620\u20131. https:\/\/doi.org\/10.5021\/ad.2015.27.5.620.","journal-title":"Ann Dermatol"},{"issue":"4","key":"1012_CR62","doi-asserted-by":"publisher","first-page":"454","DOI":"10.5021\/ad.2018.30.4.454","volume":"30","author":"NH Kim","year":"2018","unstructured":"Kim NH, Lee JB, Yun SJ. Development of vitiligo-like depigmentation after treatment of lentigo maligna melanoma with 5% imiquimod cream. Ann Dermatol. 2018;30(4):454\u20137. https:\/\/doi.org\/10.5021\/ad.2018.30.4.454.","journal-title":"Ann Dermatol"},{"issue":"11","key":"1012_CR63","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1111\/jdv.19132","volume":"37","author":"H Ren","year":"2023","unstructured":"Ren H, Akabane AL, Kelleher K, et al. Vitiligo induced by dupilumab treatment: a case series. J Eur Acad Dermatol Venereol. 2023;37(11):2259\u201361. https:\/\/doi.org\/10.1111\/jdv.19132.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl. 1","key":"1012_CR64","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.5021\/ad.21.078","volume":"35","author":"JC Kim","year":"2023","unstructured":"Kim JC, Lee ES. Progression of pre-existing vitiligo during secukinumab treatment for psoriasis. Ann Dermatol. 2023;35(Suppl. 1):S117\u201321. https:\/\/doi.org\/10.5021\/ad.21.078.","journal-title":"Ann Dermatol"},{"issue":"24","key":"1012_CR65","doi-asserted-by":"publisher","first-page":"e2233","DOI":"10.1212\/WNL.0000000000006648","volume":"91","author":"T Ruck","year":"2018","unstructured":"Ruck T, Pfeuffer S, Schulte-Mecklenbeck A, et al. Vitiligo after alemtuzumab treatment: secondary autoimmunity is not all about B cells. Neurology. 2018;91(24):e2233\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000006648.","journal-title":"Neurology"},{"issue":"4","key":"1012_CR66","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jid.2017.11.012","volume":"138","author":"JM Bae","year":"2018","unstructured":"Bae JM, Kim M, Lee HH, et al. Increased risk of vitiligo following anti-tumor necrosis factor therapy: a 10-year population-based cohort study. J Invest Dermatol. 2018;138(4):768\u201374. https:\/\/doi.org\/10.1016\/j.jid.2017.11.012.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1012_CR67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","volume":"19","author":"V Sibaud","year":"2018","unstructured":"Sibaud V. Dermatologic reactions to immune checkpoint inhibitors: skin toxicities and immunotherapy. Am J Clin Dermatol. 2018;19(3):345\u201361. https:\/\/doi.org\/10.1007\/s40257-017-0336-3.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"1012_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100064","volume":"6","author":"M Guida","year":"2021","unstructured":"Guida M, Strippoli S, Maule M, et al. Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study. ESMO Open. 2021;6(2):100064. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100064.","journal-title":"ESMO Open"},{"issue":"3","key":"1012_CR69","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jaad.2019.11.017","volume":"82","author":"C Nardin","year":"2020","unstructured":"Nardin C, Jeand\u2019heur A, Bouiller K, et al. Vitiligo under anti-programmed cell death-1 therapy is associated with increased survival in melanoma patients. J Am Acad Dermatol. 2020;82(3):770\u20132. https:\/\/doi.org\/10.1016\/j.jaad.2019.11.017.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1012_CR70","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","volume":"83","author":"AN Geisler","year":"2020","unstructured":"Geisler AN, Phillips GS, Barrios DM, et al. Immune checkpoint inhibitor-related dermatologic adverse events. J Am Acad Dermatol. 2020;83(5):1255\u201368. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.132.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1012_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.296","volume":"3","author":"H Ghani","year":"2023","unstructured":"Ghani H, Khan S, Jamgochian M, et al. Cutaneous adverse effects associated with LAG-3 inhibitor use in cancer treatment: a systematic review. Skin Health and Disease. 2023;3(6):e296. https:\/\/doi.org\/10.1002\/ski2.296.","journal-title":"Skin Health and Disease"},{"issue":"2","key":"1012_CR72","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1684\/ejd.2021.4002","volume":"31","author":"AS Algarni","year":"2021","unstructured":"Algarni AS, Ram-Wolff C, Bagot M, De Masson A. Mogamulizumab-induced vitiligo in patients with S\u00e9zary syndrome: three cases. Eur J Dermatol. 2021;31(2):213\u20136. https:\/\/doi.org\/10.1684\/ejd.2021.4002.","journal-title":"Eur J Dermatol"},{"issue":"5","key":"1012_CR73","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/cup.12298","volume":"41","author":"M Llamas-Velasco","year":"2014","unstructured":"Llamas-Velasco M, Fraga J, Kutzner H, Steegmann JL, Garc\u00eda-Diez A, Requena L. Hypopigmented macules secondary to imatinib for the treatment of chronic myeloid leukemia: a histopathologic and immunohistochemical study. J Cutan Pathol. 2014;41(5):417\u201326. https:\/\/doi.org\/10.1111\/cup.12298.","journal-title":"J Cutan Pathol"},{"issue":"2","key":"1012_CR74","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1111\/ijd.16356","volume":"62","author":"M Romagnuolo","year":"2023","unstructured":"Romagnuolo M, Alberti Violetti S, Riva D, Barberi F, Moltrasio C. Vitiligo-like lesions induced by cyclin-dependent kinase 4\/6 inhibitor palbociclib. Int J Dermatol. 2023;62(2):e98-100. https:\/\/doi.org\/10.1111\/ijd.16356.","journal-title":"Int J Dermatol"},{"key":"1012_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2023.1611115","volume":"29","author":"S Gao","year":"2023","unstructured":"Gao S, Wei G, Hao Y. Vitiligo-like lesions induced by cyclin-dependent kinase 4\/6 inhibitor palbociclib: a case report and literature review. Pathol Oncol Res. 2023;29:1611115. https:\/\/doi.org\/10.3389\/pore.2023.1611115.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"1012_CR76","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2133.2011.10311.x","volume":"165","author":"K Ezzedine","year":"2011","unstructured":"Ezzedine K, Diallo A, L\u00e9aut\u00e9-Labr\u00e8ze C, et al. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol. 2011;165(1):44\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10311.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1012_CR77","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jdv.15255","volume":"33","author":"KR Patel","year":"2019","unstructured":"Patel KR, Singam V, Rastogi S, Lee HH, Silverberg NB, Silverberg JI. Association of vitiligo with hospitalization for mental health disorders in US adults. J Eur Acad Dermatol Venereol. 2019;33(1):191\u20137. https:\/\/doi.org\/10.1111\/jdv.15255.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"1012_CR78","first-page":"255","volume":"95","author":"JI Silverberg","year":"2015","unstructured":"Silverberg JI, Silverberg NB. Vitiligo disease triggers: psychological stressors preceding the onset of disease. Cutis. 2015;95(5):255\u201362.","journal-title":"Cutis"},{"issue":"10","key":"1012_CR79","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1111\/jdv.17432","volume":"35","author":"T Passeron","year":"2021","unstructured":"Passeron T, Zouboulis CC, Tan J, et al. Adult skin acute stress responses to short-term environmental and internal aggression from exposome factors. J Eur Acad Dermatol Venereol. 2021;35(10):1963\u201375. https:\/\/doi.org\/10.1111\/jdv.17432.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1012_CR80","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2147\/CCID.S322963","volume":"14","author":"JW Liu","year":"2021","unstructured":"Liu JW, Tan Y, Chen T, Liu W, Qian YT, Ma DL. Location, spreading and oral corticosteroids are associated with insomnia in vitiligo patients: a case-control study. Clin Cosmet Investig Dermatol. 2021;14:971\u201380. https:\/\/doi.org\/10.2147\/CCID.S322963.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1012_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156493","volume":"176","author":"EMS Xerfan","year":"2024","unstructured":"Xerfan EMS, Andersen ML, Tufik S, Facina AS, Tomimori J. The impact on the quality of life and sleep complaints in a vitiligo sample and the influence of inflammatory cytokines in the interaction between vitiligo and sleep. Cytokine. 2024;176:156493. https:\/\/doi.org\/10.1016\/j.cyto.2023.156493.","journal-title":"Cytokine"},{"key":"1012_CR82","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1749-6632.2012.06616.x","volume":"1261","author":"B G\u00f3mez-Gonz\u00e1lez","year":"2012","unstructured":"G\u00f3mez-Gonz\u00e1lez B, Dom\u00ednguez-Salazar E, Hurtado-Alvarado G, et al. Role of sleep in the regulation of the immune system and the pituitary hormones. Ann N Y Acad Sci. 2012;1261:97\u2013106. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06616.x.","journal-title":"Ann N Y Acad Sci"},{"key":"1012_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2015.01.004","volume":"47","author":"KP Wright Jr","year":"2015","unstructured":"Wright KP Jr, Drake AL, Frey DJ, et al. Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain Behav Immun. 2015;47:24\u201334. https:\/\/doi.org\/10.1016\/j.bbi.2015.01.004.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"1012_CR84","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/jdv.18257","volume":"36","author":"K Bibeau","year":"2022","unstructured":"Bibeau K, Pandya AG, Ezzedine K, et al. Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA. J Eur Acad Dermatol Venereol. 2022;36(10):1831\u201344. https:\/\/doi.org\/10.1111\/jdv.18257.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1012_CR85","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/bjd.15199","volume":"177","author":"YC Lai","year":"2017","unstructured":"Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177(3):708\u201318. https:\/\/doi.org\/10.1111\/bjd.15199.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1012_CR86","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/PSY.0000000000000920","volume":"83","author":"YX Dai","year":"2021","unstructured":"Dai YX, Tai YH, Chang YT, Chen TJ, Chen MH. Posttraumatic stress disorder and the associated risk of autoimmune skin diseases: a nationwide population-based cohort study. Psychosom Med. 2021;83(3):212\u20137. https:\/\/doi.org\/10.1097\/PSY.0000000000000920.","journal-title":"Psychosom Med"},{"key":"1012_CR87","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jad.2020.05.070","volume":"274","author":"YX Dai","year":"2020","unstructured":"Dai YX, Tai YH, Chang YT, Chen TJ, Chen MH. Association between major depressive disorder and subsequent autoimmune skin diseases: a nationwide population-based cohort study. J Affect Disord. 2020;274:334\u20138. https:\/\/doi.org\/10.1016\/j.jad.2020.05.070.","journal-title":"J Affect Disord"},{"issue":"5","key":"1012_CR88","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.clinthera.2020.03.008","volume":"42","author":"N Pondeljak","year":"2020","unstructured":"Pondeljak N, Lugovi\u0107-Mihi\u0107 L. Stress-induced interaction of skin immune cells, hormones, and neurotransmitters. Clin Ther. 2020;42(5):757\u201370. https:\/\/doi.org\/10.1016\/j.clinthera.2020.03.008.","journal-title":"Clin Ther"},{"issue":"3","key":"1012_CR89","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/ddg.12957","volume":"14","author":"EM Peters","year":"2016","unstructured":"Peters EM. Stressed skin? A molecular psychosomatic update on stress-causes and effects in dermatologic diseases. J Dtsch Dermatol Ges. 2016;14(3):233\u201353. https:\/\/doi.org\/10.1111\/ddg.12957.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1012_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.843784","volume":"13","author":"E de Fran\u00e7a","year":"2022","unstructured":"de Fran\u00e7a E, Dos Santos RVT, Baptista LC, et al. Potential role of chronic physical exercise as a treatment in the development of vitiligo. Front Physiol. 2022;13:843784. https:\/\/doi.org\/10.3389\/fphys.2022.843784.","journal-title":"Front Physiol"},{"issue":"12","key":"1012_CR91","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/1346-8138.16129","volume":"48","author":"SH Ma","year":"2021","unstructured":"Ma SH, Tai YH, Dai YX, Chang YT, Chen TJ, Chen MH. Association between hepatitis C virus infection and subsequent chronic inflammatory skin disease. J Dermatol. 2021;48(12):1884\u201391. https:\/\/doi.org\/10.1111\/1346-8138.16129.","journal-title":"J Dermatol"},{"key":"1012_CR92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jdcr.2023.01.030","volume":"34","author":"E Pastukhova","year":"2023","unstructured":"Pastukhova E, Ghazawi FM. Eruptive halo nevi and new-onset vitiligo post-COVID-19 infection. JAAD Case Rep. 2023;34:43\u20134. https:\/\/doi.org\/10.1016\/j.jdcr.2023.01.030.","journal-title":"JAAD Case Rep"},{"issue":"1","key":"1012_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15196","volume":"35","author":"G Ciccarese","year":"2022","unstructured":"Ciccarese G, Drago F, Boldrin S, Pattaro M, Parodi A. Sudden onset of vitiligo after COVID-19 vaccine. Dermatol Ther. 2022;35(1):e15196. https:\/\/doi.org\/10.1111\/dth.15196.","journal-title":"Dermatol Ther"},{"issue":"7","key":"1012_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15502","volume":"35","author":"I L\u00f3pez Riquelme","year":"2022","unstructured":"L\u00f3pez Riquelme I, Fern\u00e1ndez Ballesteros MD, Serrano Ordo\u00f1ez A, Godoy D\u00edaz DJ. COVID-19 and autoimmune phenomena: vitiligo after Astrazeneca vaccine. Dermatol Ther. 2022;35(7):e15502. https:\/\/doi.org\/10.1111\/dth.15502.","journal-title":"Dermatol Ther"},{"issue":"4","key":"1012_CR95","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1468-3083.2003.00762.x","volume":"17","author":"FC Antony","year":"2003","unstructured":"Antony FC, Marsden RA. Vitiligo in association with human immunodeficiency virus infection. J Eur Acad Dermatol Venereol. 2003;17(4):456\u20138. https:\/\/doi.org\/10.1046\/j.1468-3083.2003.00762.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"1012_CR96","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jamadermatol.2024.4233","volume":"160","author":"YW Heo","year":"2024","unstructured":"Heo YW, Jeon JJ, Ha MC, Kim YH, Lee S. Long-term risk of autoimmune and autoinflammatory connective tissue disorders following COVID-19. JAMA Dermatol. 2024;160(12):1278\u201387. https:\/\/doi.org\/10.1001\/jamadermatol.2024.4233.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1012_CR97","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0190-9622(96)90490-9","volume":"35","author":"PE Grimes","year":"1996","unstructured":"Grimes PE, Sevall JS, Vojdani A. Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo. J Am Acad Dermatol. 1996;35(1):21\u20136. https:\/\/doi.org\/10.1016\/S0190-9622(96)90490-9.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1012_CR98","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/pcmr.13064","volume":"36","author":"Y Gauthier","year":"2023","unstructured":"Gauthier Y, Lepreux S, Cario-Andre M, et al. Varicella-zoster virus in actively spreading segmental vitiligo skin: pathological, immunochemical, and ultrastructural findings (a first and preliminary study). Pigment Cell Melanoma Res. 2023;36(1):78\u201385. https:\/\/doi.org\/10.1111\/pcmr.13064.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"18","key":"1012_CR99","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1016\/j.vaccine.2024.04.097","volume":"42","author":"M Shani","year":"2024","unstructured":"Shani M, Hermesh I, Feldhamer I, et al. The association between BNT162b2 vaccinations and incidence of immune-mediated comorbidities. Vaccine. 2024;42(18):3830\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.097.","journal-title":"Vaccine"},{"issue":"6","key":"1012_CR100","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.jaci.2024.01.025","volume":"153","author":"HJ Kim","year":"2024","unstructured":"Kim HJ, Kim MH, Park SJ, Choi MG, Chun EM. Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea. J Allergy Clin Immunol. 2024;153(6):1711\u201320. https:\/\/doi.org\/10.1016\/j.jaci.2024.01.025.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1012_CR101","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1684\/ejd.2024.4646","volume":"34","author":"JS Kim","year":"2024","unstructured":"Kim JS, Jeong CY, Lee GJ, Yeom SW, Nam KH. Risk of vitiligo in patients with SARS-CoV-2 vaccination or infection: a nationwide cohort study. Eur J Dermatol. 2024;34(2):150\u20137. https:\/\/doi.org\/10.1684\/ejd.2024.4646.","journal-title":"Eur J Dermatol"},{"issue":"8","key":"1012_CR102","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/1346-8138.16799","volume":"50","author":"TF Tsai","year":"2023","unstructured":"Tsai TF, Ng CY. COVID-19 vaccine-associated vitiligo: a cross-sectional study in a tertiary referral center and systematic review. J Dermatol. 2023;50(8):982\u20139. https:\/\/doi.org\/10.1111\/1346-8138.16799.","journal-title":"J Dermatol"},{"issue":"4","key":"1012_CR103","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jaad.2023.05.017","volume":"89","author":"HJ Ju","year":"2023","unstructured":"Ju HJ, Lee JY, Han JH, Lee JH, Bae JM, Lee S. Risk of autoimmune skin and connective tissue disorders after mRNA-based COVID-19 vaccination. J Am Acad Dermatol. 2023;89(4):685\u201393. https:\/\/doi.org\/10.1016\/j.jaad.2023.05.017.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1012_CR104","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/phpp.12241","volume":"32","author":"S Upala","year":"2016","unstructured":"Upala S, Sanguankeo A. Low 25-hydroxyvitamin D levels are associated with vitiligo: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed. 2016;32(4):181\u201390. https:\/\/doi.org\/10.1111\/phpp.12241.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1012_CR105","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/493213","volume":"2014","author":"M Sehrawat","year":"2014","unstructured":"Sehrawat M, Arora TC, Chauhan A, Kar HK, Poonia A, Jairath V. Correlation of vitamin D levels with pigmentation in vitiligo patients treated with NBUVB therapy. ISRN Dermatol. 2014;2014:493213. https:\/\/doi.org\/10.1155\/2014\/493213.","journal-title":"ISRN Dermatol"},{"issue":"12","key":"1012_CR106","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/jdv.15168","volume":"32","author":"A Ahmed","year":"2018","unstructured":"Ahmed A, Steed L, Burden-Teh E, et al. Identifying key components for a psychological intervention for people with vitiligo: a quantitative and qualitative study in the United Kingdom using web-based questionnaires of people with vitiligo and healthcare professionals. J Eur Acad Dermatol Venereol. 2018;32(12):2275\u201383. https:\/\/doi.org\/10.1111\/jdv.15168.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1012_CR107","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jesp.2016.09.005","volume":"69","author":"AL Burrow","year":"2017","unstructured":"Burrow AL, Rainone N. How many likes did I get? Purpose moderates links between positive social media feedback and self-esteem. J Exp Soc Psychol. 2017;69:232\u20136. https:\/\/doi.org\/10.1016\/j.jesp.2016.09.005.","journal-title":"J Exp Soc Psychol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-026-01012-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:40:38Z","timestamp":1778661638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-026-01012-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s40257-026-01012-7","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jaime Piquero-Casals served as a speaker for Incyte Corporation and medical advisor for Isdin. Cl\u00e9mence Bertold received grants and\/or honoraria from Novartis. Yolanda Gilaberte served as a consultant for Isdin, Cantabria Labs, Incyte, Almirall, UCB, and Leo Pharma, received research grants from Galderma, Almirall and Jansen, and provided lectures for Eucerin, Almirall, AbbVie, Cantabria Labs, Lilly, and Sanofi. Jos\u00e9 Luis L\u00f3pez-Estebaranz served as a consultant, participated in clinical trials, and\/or received speaking fees from Almirall, BMS, Janssen, Leo-Pharma, Lilly, AbbVie, Bioderma, Galderma, UCB, Novartis, Pierre-Fabre, Invasix, Isdin, and Incyte. Giovanni Leone has acted as a consultant for Isdin, AVITA Medical, Clinuvel, Incyte Corporation, and NAOS. Henry W. Lim has served as an investigator for Incyte, La Roche-Posay, Pfizer, and PCORI; a consultant for Isdin, Beiersdorf, Ferndale, L\u2019Or\u00e9al, Eli Lilly, Zerigo Health, Cantabria Labs, and Skinosive; and as a speaker on general education sessions for La Roche-Posay, Cantabria Labs, Pierre Fabre, NAOS, Uriage, and Pfizer. Jean Krutmann serves as a consultant to Amway, bitop, Blue Lagoon, Evonik, ISDIN, La Roche-Posay, Mary Kay, Meitu, Mistine, Mibelle, Shin, Skinceuticals, Stada, Symrise, and Vichy, and IUF obtains funding from these organizations. Khaled Ezzedine has served as a consultant for and\/or received grants from AbbVie, Almirall, Incyte, L\u2019Oreal, La Roche Posay, Pfizer, Pierre Fabre, Sanofi, and Viela Bio. Thierry Passeron is a consultant for AbbVie, ACM Pharma, Almirall, Amgen, Beiersdorf, Bristol Myers Squibb, Calypso, Caudalie, Galderma, Incyte Corporation, ISDIN, Janssen, L\u2019Oreal, Eli Lilly, Novartis, Pfizer, Roivant, SVR, Symrise, UCB, and VYNE Therapeutics. He has received grants and\/or honoraria from AbbVie, ACM Pharma, Almirall, Amgen, Astellas, Beiersdorf, Bristol Myers Squibb, Calypso, Celgene, Galderma, Genzyme\/Sanofi, GlaxoSmithKline, Incyte Corporation, Isdin, Isis Pharma, Janssen, LEO Pharma, Eli Lilly, Naos, Novartis, Pfizer, Roivant, Sun Pharmaceuticals, SVR, Takeda, UCB, and VYNE Therapeutics. He is the cofounder of NIKAIA Pharmaceuticals; and has patents on WNT agonists or GSK3b antagonist for repigmentation of vitiligo and the use of CXCR3B blockers in vitiligo. Agust\u00edn Alomar, Daniel Morgado-Carrasco, Antonio Massa, and Caio Silva de Castro have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"JPC designed the study, performed the literature search and data extraction, and drafted the manuscript. CB, YG, HWL, JK, KE, and TP contributed to study interpretation and critical manuscript revision. All authors meet authorship criteria and have approved the final version of the manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}